Essential elements for regulation Bylaw on drug demand reduction.

Slides:



Advertisements
Similar presentations
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Advertisements

Building an EU consensus for minimum quality standards in the prevention, treatment and harm reduction of drugs Quality Standards - Policy Perspectives.
Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.
The Health in Prisons Programme HIPP of WHO Why does WHO engage in prison health?
Part A: Module A5 Session 2
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
Primeri evaluacije poljske Strategije za borbu protiv droga: nacionalne i regionalne perspektive Dr Piotr Jablonski National Bureau for Drug Prevention.
International Symposium on Sexual Violence in Conflict and Beyond Bosnia and Hercegovina – Presentation Palais d’Egmont, Brussels, Belgium June 2006.
Bylaw on drug demand reduction in Serbia. Bylaw(s) - principles  should be based on existing law(s)  should complement existing laws  should not be.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
2011 Overall Objectives Contributing toward limiting Violence against Women, and fostering the role of the NCHR in combating VAW focusing on domestic.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
U n i t 5 Delivering post-crash care. © WHO, │ By the end of this unit, the trainee should be able to: describe the main actions that need to be.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Model regulations on demand reduction in Europe Bylaw on drug demand reduction.
How to survive in a non-supportive environment: Experience from Russia Ivan Varentsov (Andrey Rylkov Foundation) AIDS 2014, Melbourne.
Sofia City of Oslo Agency for Alcohol and Drug Addiction Services/Competence Centre Agency for Alcohol and Drug Addiction Services, Competence.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
HIV and drug prevention in Estonia Harm reduction services
Treatment of drug addiction in prisons
Development and Implementation of the Practical Model of Gradual Social Integration RECOMMENDATIONS for the development of the Practical Model.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Domestic violence-not with us! 27 June -5 July 2011 Poland, Nowy Sacz “SOS - Families at risk” Foundation VARNA, BULGARIA.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Dorcas Sithole Mental Health Department Ministry of Health & Child Welfare 1.
Harm Reduction.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
The Governance of Care: Mapping Local Influences on IDU Health Interventions in a Polish City Sobeyko J (1)(8), Leszczyszyn-Pynka M (1)(2), Duklas T (7),
Violence against Women: Do the Governments Care? Mapping the state response in CEE and CIS countries A project by the Open Society Institute Network Women’s.
North Carolina TASC Clinical Series Training Module One: Understanding TASC.
The WHO HPH Standards Professor Hanne Tønnesen MD PhD CEO Clinical Health Promoting Centre – WHO-CC for Evidence-based Health Promotion in Hospitals and.
Seite 1 BMZ Health Sector Strategy (Health Division) Framework, principles and thematic areas of German Development Aid for Health Dr A Stadler.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
STRATEGY OF DRUG AND HIV/AIDS PREVENTION IN THE CITY AND DISTRICTS OF TALLINN Ene Tomberg Department of Social Welfare and Health Care of Tallinn.
ROMANIA MINISTRY OF HEALTH GENERAL DIRECTORATE OF PUBLIC HEALTH Health Promotion Unit Cristina Padeanu, MSc.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
HIV in Europe, Stockholm 2 November 2009 Developing Regional HIV T&C Policy Framework Lali Khotenashvili Communicable Diseases Unit, WHO Regional Office.
Keep your promise to women and girls Violence against Women and Girls in National AIDS plans.
Integrating Mental Health and Psychosocial Interventions into World Bank Lending for Conflict Affected Populations: A Toolkit About the Toolkit: Provides.
Maximising professionalism Module 6. Contents The tasks The roles The collaboration between staff The communication between staff and patients The physical.
Medical law and its place in the system of law and legislation in Ukraine. Legislative provision in healthcare in Ukraine.  The concept, object, method.
Section 5: Principles of Drug Addiction Treatment 1.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
ASRH and related policies, legislations, guidelines, standards and plan of action.
NDPHS Expert Group on HIV/AIDS and Associated Infections Draft problem tree 5 December, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen.
Week 12. Lecture 2. Health Law & the EU Cross-border healthcare: patients’ rights.
ENSURING BETTER PROTECTION FOR WOMEN FROM THEIR FIRST CALL FOR HELP UNTIL THEY REBUILD THEIR LIVE Prepared by Špela Veselič, Association SOS Help-line.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Education and Training Centre for Children - Need for Minimum Standards.
EG HIV/AIDS & AI Internal Strategy and Action Plan Country priorities according to a survey in January-February 2014.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
An Age of hope: a National Effort for Corrections, Rehabilitation and Social Re-integration of Offenders PRESENTATION ON CURRENT HIV AND AIDS PROJECTS.
MODULE 3 Harm reduction advocacy
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Sendai Framework for Disaster Risk Reduction
Accessing Cannabis Users – Survey on Good Practice Approaches
Addressing Drug Use Together Through a Health Based Approach:
Purposes of the Convention
Decriminalisation Policy and the role of the CDT
Head of Research centre
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
German Drug and Addiction Policy
Presentation transcript:

Essential elements for regulation Bylaw on drug demand reduction

Working methode for drafting the bylaw  Identify the essential elements for regulation of demand reduction  Which elements are already regulated in Serbian legislation?  Model regulations in Europe  Need for regulation through the bylaw

Topics which need to be regulated I.General Provisions II.Prevention III.Treatment of addiction IV.Harm reduction V.Rehabilitation and social reintegration VI.Justice system (prosecution, courts, prisons..) VII.Sanctions / penalties

General Provisions 1.Scope of the bylaw : The aim of the regulation should be: – to prevent and counteract drug addiction, – to establish a legal framework for dealing with consumers of psychoactive substances, – to establish tasks and prerogatives of relevant institutions/organisations/entities involved in preventing and counteracting drug addiction, – to establish sanctions for violating the provisions

General Provisions 2.Areas to be regulated: Prevention of drug abuse, reduction of the number of drug users as well as the amount of drugs consumed, Treatment of drug users and addicts, Reduction of the health and social harm associated with drug use, Rehabilitation, reintegration of addicted persons into society.

General Provisions 3.Guiding principles (I): Programmes and measures in the field of Demand Reduction should – ensure health and security of individuals and society, – acknowledge that addiction is a disease which can and should be treated, – respect Human Rights, in particular guarantee the right to be treated

General Provisions 3.Guiding principles (II): Programmes/measures in the field of demand reduction should – provide help to drug users (treatment, counselling, rehabilitation, reintegration) in principle on a voluntary basis, notwithstanding other legal regulation, – constitute a comprehensive, integrated and coherent system of Demand Reduction, – be easily accessible to all those who need them

General Provisions 3.Guiding principles (III): Programmes and measures in the field of Demand Reduction should – comply with the International Drug Control Conventions of the UN, – be complementary to Supply Reduction programmes ("Balanced Approach") – be based on (scientific) evidence and on the relevant standards of conduct, – be systematically monitored.

General Provisions 4.Relevant institutions/ entities / organisations (I) – Government administration, – Regions, Local Communities, Special drug related institutions – Educational institutions (Kindergartens, Schools, Universities, Training institutions) – Health care system – Judicial system (Police, Courts, Prisons)

General Provisions 4.Relevant institutions/ entities / organisations (II) – Welfare organisations – NGO’s – Civil Society – Media Responsibilities and competences should be clearly defined within the legal framework

General Provisions 5.Coordination – All the relevant stakeholders should participate in planning, organisation and implementation of programmes and measures – All relevant activities should be coordinated on the local, regional, national level by respective coordinating bodies – Demand Reduction policy should be matched with Supply Reduction policy ("balanced approach”)

General Provisions 6.Strategy and Action Plan Strategy and Action Plan should form the basis for measures for counteracting drug addiction

General Provisions 7.Research – Research in all the sectors of demand reduction is necessary and must be funded by the State and other institutions – International cooperation in drug research is essential. Results of research performed in other countries should be taken into account.

General Provisions 8.Monitoring – National Monitoring Centre is to be established – Records on: consumption, drug related diseases, treatment, drug related deaths

Prevention of drug use 1.Forms of prevention a)Universal prevention (Programmes and measures to avoid that population take drugs) b)Selective and indicated prevention (Programmes and measures targeting at-risk groups and individuals)

Prevention of drug use 2.Means of prevention a)Universal prevention: educational activities, health promotion programmes, informational and awareness raising activities b)Selective and indicated prevention: counselling early intervention support/assistance

Prevention of drug use 3.Institutions/organisations responsible for / dealing with prevention 4.Financing of Prevention Financing of prevention is needed to ensure the sustainability of prevention activities

Treatment of addiction Treatment of addiction disease = scope of the bylaw Treatment of other diseases with narcotics (e.g. pain) – symptomatic treatment = to be regulated elsewhere Drug addiction treatment must be integral part of the health and social care system

Treatment of addiction Range of treatment methods – Detoxification – Medically assisted treatment (substitution treatment) – Abstinence-oriented treatment – Psycho-social assistance Any method must comply with the agreed professional standards (state of the art)

Treatment of addiction Settings for treatment: – Outpatient – Inpatient (residential) – Outreach work

Treatment of addiction Aim of the treatment: – (Gradual) reduction of drug consumption with the ultimate goal of abstinence – Improvement of the health status and the quality of life of the addict – Treatment of (psychiatric) co-morbidities

Treatment of addiction Institutions / organisations / persons providing treatment – Medical doctors / nurses / psychologist / social workers – Healthcare centres, hospitals, reference centres, prisons – Social services, offices for youth ← Qualification or certification required for institutions and/or professionals

Treatment of addiction Special provisions for substitution treatment (I) – Special licence for ST required for medical doctors – List of psychoactive substances that are expressively admitted for ST – Registration of all medical doctors with substitution licence and of all cases of substitution treatment (in anonymised form) in order to avoid double treatment

Treatment of addiction Special provisions for substitution treatment (II) – Titration of dose and quantities of substitution substances to be administered – Indications, contraindications and refusal of treatment – Medical treatment should be combined with psycho- social assistance wherever needed by the patient, – Administrative requirements / control measures

Treatment of addiction Financing of Treatment Financing of treatment is needed to ensure the sustainability of treatment activities

Harm reduction Definition – Programmes and measures aiming primarily at reducing the adverse health and social consequences associated with the use of psychoactive substances – “Aid for survival” (GER) – Must be an integral part of a comprehensive and coherent continuum of demand reduction measures – Must be complementary to prevention, treatment and rehabilitation, not replace them

Harm reduction Types of measures, interventions and services(I): – Low threshold facilities, drop-in centres, shelters, contact and information units – Medication and emergency kits for management of overdoses in appropriate places (e.g. naloxone distribution programmes), – Vaccination programmes (against Hepatitis a.o.), – Voluntary HIV and HCV counselling and testing, – Needle/syringe exchange programmes – Measures to ensure safer use,

Harm reduction Types of measures, interventions, services (II): – Services for the management of sexually transmitted infections, particularly to those involved in sex work, – Diagnostic and treatment of HIV, HCV and TB in injecting drug users – Well-equipped street-workers and peer outreach workers units, – Medically supervised outreach facilities (so called “Drug consumption rooms”) – Violence prevention programmes – Others....

Harm reduction Types of measures, interventions and services: – Services for the management of sexually transmitted infections (particularly for sexworkers), – Diagnostic and treatment of HIV, HCV and TB in injecting drug users – Street-workers and peer outreach workers units, – Medically supervised outreach facilities (so called “Drug consumption rooms”) – Violence prevention programmes – Others….

Harm reduction Integration of harm reduction into public health system and cooperation between e different stakeholders and actors is essential Financing of harm reduction is needed to ensure the sustainability of harm reduction activities

Rehabilitation and Social Reintegration Measures aiming at assisting persons using drugs in participating in social interaction, particularly in work life. Institutions/organisations providing Rehabilitation and Reintegration: social care institutions and welfare system unemployment offices prisons after-care programmes, therapeutic communities NGOs others...

Rehabilitation and Social Reintegration Cooperation between institutions is absolutely essential All existing and appropriate programmes and measures of Rehabilitation and Reintegration should be accessible for drug users Special programmes and measures for the Rehabilitation and Reintegration of drug users should be established Sustainable financing is needed

Justice system Principle: Treatment instead of prison Rules for preventing and counteracting of drug addiction within prisons Equal rights for addiction care in and out-side the prison Reintegration into society after prison

Essential elements for regulation Thank you for your attention!